Other mechanisms that can stimulate clotting and thrombosis in cancer include the release of tissue factor (TF) by tumor cells and, as mentioned above, by tumor-derived MPs that stimulate the extrinsic coagulation cascade, resulting in the activation of factor X, leading to thrombin formation, fibrin synthesis and platelet activation [96,121]. The gene discussed is TF; the disease is cancer.